Clinical Trial

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

Name: Impact of Targeted Therapy on Cancer-Related Cognitive Impairment — clinical trial record (NCT07638007)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TKI

Recruiting

View on ClinicalTrials.gov →

Summary

This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do not receive TKI therapy.

Trial Details

NCT Number	NCT07638007
Lead Sponsor	University of Rochester NCORP Research Base Collaborators: National Cancer Institute (NCI)
Conditions	Disease/Condition Name Cancer-related Cognitive Dysfunction, Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia, BCR-ABL1 Positive
Enrollment	400 participants
Start Date	2025-11-21
Primary Completion	2029-02-28 (estimated)
Study Completion	2029-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-06-10